Eton Pharmaceuticals (ETON)
(Delayed Data from NSDQ)
$15.26 USD
+0.53 (3.60%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $15.29 +0.03 (0.20%) 5:54 PM ET
4-Sell of 5 4
D Value C Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Eton Pharmaceuticals, Inc. has a market cap of $395.02M, which represents its share price of $14.73 multiplied by its outstanding shares number of 26.82M. As a small-cap company, ETON's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ETON 15.26 +0.53(3.60%)
Will ETON be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ETON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ETON
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why
ETON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
Other News for ETON
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, ...
BlackRock, Inc. Expands Stake in Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc (ETON) Shares Up 8.03% on Jul 18
Eton Pharma Near Term Catalysts Vanish
Eton Pharmaceuticals management to meet with B. Riley